Clinical trial registry record

PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 3, 2023.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05796011
Last registry update
April 3, 2023
Status
Unknown
Phase
Phase not reported
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Enrollment
30
Countries
China
Match confidence
70%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
30
Population
ALL · 50 Years to 85 Years
Duration
2022-07-06 to 2024-01-01
Intervention
hearing aids; without hearing intervention; healthy control
Comparator
Not reported
Outcomes measured
pure tone average — through study completion, an average of 6 months; Speech recognition score — through study completion, an average of 6 months; MMSE score and grade — through study completion, an average of 6 months; MoCA score and grade — through study completion, an average of 6 months; Otorhinolaryngological diseases and daily life self-assessment questionnaire — through study completion, an average of…; Resting Electroencephalogram — through study completion, an average of 6 months; Functional Near-Infrared Spectoscopy — through study completion, an average of 6 months; Positron emmision tomography — through study completion, an average of 6 months
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 70% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Hearing ageing · 70%Source terminology contains: age-related hearing loss. Title supplies longevity context: age-related. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

hearing aging
Open primary sourceExport JSON